Xbiotech Inc (XBIT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Xbiotech Inc   (NASDAQ: XBIT)


Xbiotech Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Xbiotech Inc's ROI in the second quarter of 2026?
Xbiotech Inc recorded a cumulative net loss of $-45 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -31.23%.

Within the Healthcare sector 373 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3165 to 3432.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -20.71 % -17.28 % -15.87 % -14.52 % -14.64 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 130 137 142 169 175
Return On Investment (TTM) -31.23 % -25.8 % -27.5 % -16.56 % -15.45 %
XBIT's Overall Ranking # 3432 # 3165 # 3150 # 2810 # 2584
Seq. Investment Change TTM -7.15 % -5.98 % -5.94 % -3.43 % -3.13 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -45 -40 -46 -29 -28

XBIT Company Profile >> Back to XBIT Roi Comparisons >> See Annual XBIT Return On Investment



Return On Investment XBIT's Ranking
Within: No.
Industry # 147
Sector # 374
Overall # 3432

Return On Investment Statistics
High Average Low
288.29 %
-6.22 %
-68.99 %
(Dec 31 2019)   (Mar 31 2017)







Financial Statements
Xbiotech Inc's II. Quarter Investments $ 130 Millions XBIT's Balance sheet
Xbiotech Inc's II. Quarter Income $ -7 Millions Quarterly XBIT's Income Statement
XBIT's Income by Division See XBIT's Income by Division


XBIT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 142 184 221 242 272
Y / Y Investment Growth -22.74 % -16.56 % -8.89 % -10.93 % -22.31 %
Net Income in Millions -46 -39 -25 -33 -17
Y / Y Net Income Growth - - - - -
Annual Return On Investment -32.04 % -20.94 % -11.14 % -13.59 % -6.41 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XBIT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XBIT's Competitors
Subscribers only: Roi for Xbiotech Inc's Suppliers
Subscribers only: Return On Investment for XBIT's Customers

Other Ratios
XBIT's Roa XBIT's Inventory Turnover Ratio XBIT's Growth Rates XBIT's Dividend Statistics
XBIT's Profitability Ratios XBIT's Asset Turnover Ratio XBIT's Dividend Growth
XBIT's Roe XBIT's Valuation Ratios XBIT's Financial Strength Ratios XBIT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-03T12:24:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.